# BSF Enterprise Plc accelerates commercialisation prospects with ground-breaking collaboration

- Link: https://www.directorstalkinterviews.com/bsf-enterprise-plc-accelerates-commercialisation-prospects-with-ground-breaking-collaboration/4121194059
- Published: 2025-04-25T12:19:37+01:00
- Author: Emily Johnson

**BSF Enterprise PLC** (LON:BSFA), a leading innovator in tissue-engineered materials,
has announced that its wholly-owned subsidiary, **Lab-Grown Leather Ltd** (**LGL**)
is transitioning its lab-grown leather technology from lab-scale to future products
in a major step towards commercialization. 

A frontrunner of these future products is Elemental X™ – the boldest realisation
of what **LGL’s** lab-grown leather can achieve. Developed using its proprietary
Advanced Tissue Engineering Platform (**ATEP™**), it represents a new era of luxury
and performance – where leather doesn’t just echo tradition, it redefines what’s
possible.

In a pioneering venture, Lab-Grown Leather Ltd has partnered with **VML** (a group
company of [WPP PLC](https://www.directorstalkinterviews.com/ftse-company/wpp-plc/wpp.l))
and genomic engineering leader **The Organoid Company** to create the first-ever
leather inspired by the DNA of an extinct species: _Tyrannosaurus rex._

Creative agency **VML** (a group company of WPP PLC), genomic engineering leader**
The Organoid Company**, and sustainable biotechnology pioneer **Lab-Grown Leather
Ltd**. (a group company of BSF Enterprise PLC – LSE:BSFA) today announced a first-
of-its-kind partnership to lead the way towards a more sustainable and ethical future
for the luxury materials industry. 

The new collaboration will start developing and producing a high-quality alternative
to traditional leather that’s cruelty-free and eco-friendly. There’s one more detail
that makes this ground-breaking new material really special: it’s engineered using
T-Rex DNA that has been synthesized using sequences from fossilized collagen.

The new venture combines VML Netherlands’ creative innovation expertise, The Organoid
Company’s advanced genome engineering capabilities, and Lab-Grown Leather’s proprietary
Advanced Tissue Engineering Platform (ATEP™), to create a next-gen material that
could shape the future of luxury goods while advancing sustainable manufacturing
practices.

Using fossilized T-Rex collagen as a blueprint, the production process will involve
engineering cells with synthetic DNA, designed by The Organoid Company, which are
then integrated into Lab-Grown Leather’s Elemental-X™ product stream. Unlike other
bio-based alternatives, Lab-Grown Leather’s  “scaffold-free” approach allows cells
to create their own natural structure, resulting in a material that is structurally
identical to traditional leather.

Dinosaurs evolved to survive in extreme environments-conditions our planet is once
again beginning to face due to accelerated climate change. This offers a new lens
through which to explore ancient biology as a blueprint for next-generation, lab-
cultivated materials. Engineered using Lab-Grown Leather Ltd.’s advanced tissue 
engineering platform, T-Rex leather is a cell-grown performance material that goes
beyond imitation-offering natural durability, repairability, and the tactility expected
in high-end leather goods.

As the first-ever example of leather developed from a prehistoric species, T-Rex
leather represents not just a sustainable alternative but a pioneering step in exploring
how ancient biology can inspire sustainable, high-performance materials in the future.

The environmental and ethical implications of bio-engineered leather are significant.
Traditional leather production is linked to extensive deforestation, and established
leather tanning processes often involve the use of harmful chemicals like chromium,
which can lead to pollution. The new T-Rex leather technology – like other forms
of Elemental Leather™ from Lab-Grown Leather Ltd – offers a path to dramatically
reduce these environmental impacts while eliminating animal cruelty concerns associated
with traditional leather production.

Initial applications will focus on accessories, with the ambition to produce a luxury
fashion item as its flagship commercial product by the end of 2025. Following this
proof of concept, increased production will open up opportunities to expand into
sectors beyond fashion, such as the automotive industry. The material is fully biodegradable
while maintaining the durability and repairability of traditional leather, offering
a sustainable, cruelty-free, and traceable alternative for future generations of
consumers, who demand both innovation and environmental responsibility.

Professor Che Connon of Lab-Grown Leather commented _“**Our proprietary advanced
tissue engineering platform has once again proven its versatility. By collaborating
with VML and The Organoid Company, we’re unlocking the potential to engineer leather
from prehistoric  species, starting with the formidable T-Rex. This venture showcases
the power of cell-based technology to create materials that are both innovative 
and ethically sound.”**_

Thomas Mitchell, CEO of The Organoid Company, added: **_“This project is a remarkable
example of how we can harness cutting-edge genome and protein engineering to create
entirely new materials. By reconstructing and optimizing ancient protein sequences,
we can design T. Rex leather, a biomaterial inspired by prehistoric biology, and
clone it into a custom-engineered cell line. At The Organoid Company, we’re passionate
about pushing the frontiers of synthetic biology, not just to transform medicine,
but to support companies like Lab-Grown Leather and VML to pioneer sustainable alternatives
for the materials of tomorrow.”_

**_“With T-Rex leather we’re harnessing the biology of the past to create the luxury
materials of the future. This ground-breaking collaboration represents the intersection
of creative innovation and cutting-edge biotechnology, much like we did with our
Mammoth Meatball project”_** concluded Bas Korsten, Global Chief Creative Officer,
Innovation & CCO EMEA at VML. **_“We are at a point in our industry’s history where
we need to productise our creativity. The production of T-Rex leather demonstrates
VML’s commitment to pioneering new grounds and shaping the future of our industry.”_**_
**
APPENDIX**

Lab-Grown Leather’s bio-engineered materials span the following market sectors:

·      a $780B Global Leather Goods Market (4.6% CAGR 2025-2035)

·      a $41.20B smart textile market (22.51% CAGR).

·      a $47.9B bio-based materials market growing 10-15% annually

**About VML** 

VML is a leading creative company that combines brand experience, customer experience,
and commerce, to create connected brands that drive growth. The agency is celebrated
for its innovative and award-winning work with blue chip client partners including
AstraZeneca, Colgate-Palmolive, Ford, Microsoft, Nestlé, The Coca-Cola Company, 
and Wendy’s. 

VML is recognized as a Leader by Forrester Wave™ reports for Commerce Services, 
Marketing Creative and Content Services, and is a Strong Performer in the Forrester
Wave™: CX Strategy Consulting Services. It was also named a Leader in IDC MarketScape:
Adobe Experience Cloud Professional Services and a Visionary in the Gartner Magic
Quadrant for Digital Experience Services. VML’s specialist health network, VML Health,
is also one of the world’s largest and most awarded health agencies. 

VML’s global network is powered by 26,000 talented people across 60-plus markets,
with principal offices in Kansas City, New York, Detroit, London, São Paulo, Shanghai,
Singapore, and Sydney.

**About Lab-Grown Leather**

Lab-grown Leather Ltd is a new business, based in Newcastle Upon Tyne UK, being 
developed by BSF Enterprise Plc to scale up the technical development and operational
sales of animal skin products. BSF Enterprise Plc, founded in 2018 and listed on
the London Stock Exchange in 2019, is focused on developing sustainable biotechnological
solutions through industrial tissue engineering. 

Lab-grown Leather Ltd focuses on producing a cultivated dermal skin, that replicates
natural skin and once tanned has an identical composition to traditional leather,
guaranteeing the same performance. its lead product is called “Elemental Leather
^(TM)“

Lab-grown Leather Ltd utilizes a unique “scaffold-free” tissue engineering technology.
This means that unlike some other lab-grown leather approaches and many plant-based
alternatives, Elemental Leather^(TM) is made without additives or scaffolding, allowing
the cells (including engineered cells) to create their own natural structure. This
is considered a significant advantage, leading to a more authentic and durable end
product that is more compatible with traditional leather processing techniques, 
including tanning.  While other bio-based alternatives exist, such as plant-based
fungi-based and inorganic glass fibre-based leathers, Elemental Leather^(TM) is 
claimed to be “true leather” as it is made entirely from animal cells and the proteins
they produce creating the same structure as traditional leather. This results in
a material that is structurally and genetically identical to traditional leather,
offering the same durability, feel, and versatility.

**About The Organoid Company** 

The Organoid Company, a leader in genome engineering, is dedicated to reducing the
complexity of drug development by linking cost-effective organoid disease models
with digital biology. Its platform enables the scalable production of stem cell-
derived organoids and integrates advanced digital biology tools to accelerate the
therapeutic design-test-build cycle. By combining predictive in vitro systems with
computational drug design, The Organoid Company is changing the way drug discovery
is done to enable fast and targeted therapeutic development for research groups 
and biotech companies of all sizes.

As part of an innovative initiative to develop bioleather from the extinct Tyrannosaurus
genus commonly known as T-rex, The Organoid Company has been approached for its 
expertise in protein and genome engineering to help recreate this unique material.

The Organoid Company is an innovative biotechnology company supporting the global
life science industry with offices located in the Netherlands’ Innovation Quarter.

Share on: